Taking the Global Stroke Resolution as an Opportunity to Promote High-Quality Development of Cerebrovascular Disease Prevention and Treatment in China

doi:10.3969/j.issn.1673-5765.2026.07.001

Chinese Journal of Stroke ›› 2026, Vol. 21 ›› Issue (7): 789-796.DOI: 10.3969/j.issn.1673-5765.2026.07.001

Previous Articles Next Articles

Taking the Global Stroke Resolution as an Opportunity to Promote High-Quality Development of Cerebrovascular Disease Prevention and Treatment in China

LI Tianqi^1,2, YANG Xin^1,2, JIANG Yong^1,2,3, WANG Yongjun^1,2,3,4,5

1 National Collaborating Center for Neurological Disorders Prevention, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China;
2 National Leading Unit for Cerebrovascular Disease Prevention and Treatment Technology, National Center for Neurological Disorders, Beijing 100070, China;
3 China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China;
4 National Center for Healthcare Quality Management in Neurological Diseases, Beijing 100070, China;
5 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China

Received:2026-06-02 Revised:2026-07-07 Accepted:2026-07-10 Online:2026-07-20 Published:2026-07-20
Contact: JIANG Yong, E-mail: jy78@vip.sina.com WANG Yongjun, E-mail: yongjunwang@ncrcnd.org.cn

以全球卒中决议为契机，推动中国脑血管病防治高质量发展

李天琪^1，2，杨昕^1，2，姜勇^1，2，3，王拥军^{1，2，3，4，5}

1 北京100070首都医科大学附属北京天坛医院，中国神经系统疾病人群防治合作中心办公室
2 北京100070国家级脑血管病防治技术牵头单位，国家神经疾病医学中心
3 北京100070首都医科大学附属北京天坛医院神经系统疾病国家临床医学研究中心
4 北京100070国家神经系统疾病医疗质量控制中心
5 北京100070首都医科大学附属北京天坛医院神经病学中心

通讯作者: 姜勇 jy78@vip.sina.com 王拥军 yongjunwang@ncrcnd.org.cn

Abstract

Abstract: Stroke is the second leading cause of death and the third leading cause of disability globally, with a continuously rising disease burden. In May 2026, the 79th World Health Assembly adopted the first stroke-specific resolution—reducing the burden of stroke: strengthening prevention, acute care, rehabilitation and health system readiness. China bears one of the heaviest stroke burdens worldwide, and faces persistent challenges in risk factor control, equitable acute care, full-course management, and primary healthcare resilience. This article systematically interprets the resolution’s core content and global health governance implications, analyzes the current status and bottlenecks in stroke prevention and treatment in China, and proposes an implementation pathway characterized by “prevention advancement, emergency acceleration, rehabilitation extension, system strengthening, and digital empowerment.” Future efforts should consolidate primary prevention and opportunistic screening, promote the integrated prevention and treatment of stroke and brain health conditions such as cognitive impairment, optimize regional coordinated emergency networks, strengthen the continuous service chain of rehabilitation and secondary prevention, establish a national cerebrovascular disease surveillance and registry system, and enhance digital technology and multi-sectoral collaboration, thereby accelerating the transition toward full-course health management and contributing China’s action to global stroke prevention and control.

Key words: Stroke; World Health Assembly; Stroke resolution; Prevention and control system; Brain health; China’s action

摘要： 卒中是全球第二大死亡病因和第三大致残原因，且其疾病负担持续攀升。2026年5月，第79届世界卫生大会通过了首个卒中专项决议—减轻卒中负担：加强预防、急性期治疗、康复和卫生系统准备。中国是全球卒中负担最重的国家之一，在卒中危险因素控制、救治均衡性、全病程管理及基层体系韧性方面仍面临重大挑战。本文系统解读该决议的核心内涵与全球卫生治理意义，分析中国卒中防治现状与瓶颈，提出“预防前移、急救提速、康复延伸、体系强化、数字赋能”的实施路径。未来中国应夯实卒中的一级预防与机会性筛查，推进卒中与认知障碍等脑健康相关疾病的同防同治，优化区域协同急救网络，健全康复与二级预防连续服务链，建立全国脑血管病监测登记系统，强化数字技术与多部门协同支撑，加快向全病程健康管理转型，为全球卒中防治贡献中国力量。

关键词: 卒中; 世界卫生大会; 卒中决议; 防治体系; 脑健康; 中国行动

CLC Number:

LI Tianqi, YANG Xin, JIANG Yong, WANG Yongjun. Taking the Global Stroke Resolution as an Opportunity to Promote High-Quality Development of Cerebrovascular Disease Prevention and Treatment in China[J]. Chinese Journal of Stroke, 2026, 21(7): 789-796.

李天琪, 杨昕, 姜勇, 王拥军. 以全球卒中决议为契机，推动中国脑血管病防治高质量发展[J]. 中国卒中杂志, 2026, 21(7): 789-796.

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.chinastroke.org.cn/EN/10.3969/j.issn.1673-5765.2026.07.001

https://www.chinastroke.org.cn/EN/Y2026/V21/I7/789

References

[1] GBD 2021 Stroke Risk Factor Collaborators. Global，regional，and national burden of stroke and its risk factors，1990-2021：a systematic analysis for the global burden of disease study 2021[J]. Lancet Neurol，2024，23（10）：973-1003.
[2] Owolabi M O，Thrift A G，Mahal A，et al. Pragmatic solutions to reduce the global burden of stroke：a World Stroke Organization-Lancet Neurology Commission[J]. Lancet，2023，402（10408）：1162-1217.
[3] World Health Assembly. Reducing the burden of stroke：strengthening prevention，acute care，rehabilitation and health-system readiness（WHA79.10）[EB/OL].（2026-05-23）[2026-05-28]. https://apps.who.int/gb/ebwha/pdf_files/WHA79/A79_R10-en.pdf.
[4] Tu Wenjun，Zhao Zhenping，Yin Peng，et al. Estimated burden of stroke in China in 2020[J/OL]. JAMA Netw Open，2023，6（3）：e231455. https://doi.org/10.1001/jamanetworkopen.2023.1455.
[5] O’Donnell M，Chin S L，Rangarajan S，et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries（INTERSTROKE）：a case-control study[J]. Lancet，2016，388（10046）：761-775.
[6] Akinyemi R O，Ovbiagele B，Adeniji O A，et al. Stroke in Africa：profile，progress,prospects and priorities[J]. Nat Rev Neurol，2021，17（10）：634-656.
[7] Verhoeven J I，Allach Y，Vaartjes I C H，et al. Ambient air pollution and the risk of ischaemic and haemorrhagic stroke[J/OL]. Lancet Planet Health，2021，5（8）：e542-e552. https://doi.org/10.1016/S2542-5196(21)00145-5.
[8] Martins S C O，Pontes-Neto O M，Sampaio Silva G，et al. Implementation of a national stroke network and its impact on reperfusion rates in Brazil[J]. Lancet Reg Health Am，2024，30:100683.
[9] SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control[J]. N Engl J Med，2015，373（22）：2103-2116.
[10] Svendsen J H，Diederichsen S Z，Højberg S，et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke（The LOOP Study）[J]. Lancet，2021，398（10310）：1507-1516.
[11] Carnicelli A P，Hong H，Connolly S J，et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation：patient-level network meta-analyses of randomized clinical trials[J]. Circulation，2022，146（22）：1591-1601.
[12] Kleindorfer D O，Towfighi A，Chaturvedi S，et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack[J/OL]. Stroke，2021，52（7）：e364-e467. https://doi.org/10.1161/STR.0000000000000375.
[13] Feigin V L，Brainin M. Prevention of stroke：a strategic global imperative[J]. Nat Rev Neurol，2021，17（7）：381-392.
[14] Kjellström T，Norrving B，Shatchkute A. Helsingborg declaration 2006 on European stroke strategies[J]. Cerebrovasc Dis，2007，23（3）：229-241.
[15] Jhaveri B D，Shah N，Prabhakaran S，et al. Association of stroke center certification with patient outcomes and process of care：a systematic review and meta-analysis[J]. JAMA Neurol，2019，76（10）：1219-1229.
[16] Reeves M J，Fonarow G C，Smith E E，et al. Twenty years of sustained improvement in quality of care and outcomes for patients hospitalized with stroke or transient ischemic attack：data from the get with the guidelines-stroke program[J]. Stroke，2024，55（10）：3018-3030..
[17] Bernhardt J，Langhorne P，Lindley R I，et al. Efficacy and safety of very early mobilisation within 24 h of stroke onset（AVERT）：a randomised controlled trial[J]. Lancet，2015，386（9988）：46-55.
[18] Bernhardt J，Hayward K S，Kwakkel G，et al. Agreed definitions and a shared vision for new standards in stroke recovery and rehabilitation[J]. Lancet Neurol，2017，16（10）：832-842.
[19] Zhang Tong，Li Xingzhu，Jin Tianyu，et al. Analysis of stroke burden in China from 1990 to 2021 and projections for the next decade[J]. Neuroepidemiology，2025，59（5）：505-516.
[20] Ma Qingfeng，Li Rui，Wang Lijun，et al. Temporal trend and attributable risk factors of stroke burden in China，1990-2019：an analysis for the global burden of disease study 2019[J/OL]. Lancet Public Health，2021，6（12）：e897-e906. https://doi.org/10.1016/S2468-2667(21)00228-0.
[21] Zhang Mei，Shi Yu，Zhou Bin，et al. Prevalence，awareness，treatment，and control of hypertension in China，2004-2018：findings from six rounds of a national survey[J/OL]. BMJ，2023，380：e071952. https://doi.org/10.1136/bmj-2022-071952.
[22] Yang Wei，Lu Jianming，Weng Jianping，et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med，
2010，362（12）：1090-1101.
[23] Xu Yan，Wang Limin，He Jianghua，et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA，2013，310（9）：948-959.
[24] Wang Limin，Peng Wei，Zhao Zhipeng，et al. Prevalence and treatment of diabetes in China，2013-2018[J]. JAMA，2021，326（24）：2498-2506.
[25] Yang Wei，Xiao Jizhe，Yang Zhenjiang，et al. Serum lipids and lipoproteins in Chinese men and women[J]. Circulation，2012，125（18）：2212-2221.
[26] Wang Limin，Zhou Bin，Zhao Zhipeng，et al. Body-mass index and obesity in urban and rural China：findings from consecutive nationally representative surveys during 2004-2018[J]. Lancet，2021，398（10294）：53-63.
[27] Zhang Mei，Yang Lei，Wang Limin，et al. Trends in smoking prevalence in urban and rural China，2007 to 2018：findings from 5 consecutive nationally representative cross-sectional surveys[J/OL]. PLoS Med，2022，19（8）：e1004064. https://doi.org/10.1371/journal.pmed.1004064.
[28] 巢宝华，刘建民，王伊龙，等. 中国脑卒中防治：成就、挑战和应对[J]. 中国循环杂志，2019，34（7）：625-631.
Chao Baohua，Liu Jianmin，Wang Yilong，et al. Stroke prevention and control in China：achievements，challenges and solutions[J]. Chin Circ J，2019，34（7）：625-631.
[29] 国家卫生和计划生育委员会神经内科医疗质量控制中心. 中国卒中中心建设指南[J]. 中国卒中杂志，2015，10（6）：499-507.
Neurology Medical Quality Control Center，National Health and Family Planning Commission. Guideline for the construction of stroke centers in China [J]. Chin J Stroke，2015，10（6）：499-507.
[30] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于确定省级、市级脑血管病防治技术牵头单位的通知[EB/OL].（2024-04-11）[2026-05-28]. https://www.nhc.gov.cn/ylyjs/gzdt/202404/a9da29dc36424652a456b7ea1d12a8dc.shtml.
[31] Gu Huiqiang，Yang Xia，Wang Chunjiang，et al. Clinical characteristics，management，and in-hospital outcomes in patients with stroke or transient ischemic attack in China[J/OL].
JAMA Netw Open，2021，4（8）：e2120745. https://doi.org/10.1001/jamanetworkopen.2021.20745.
[32] Wangqin Ruiqing，Laskowitz D T，Wang Yongjun，et al. International comparison of patient characteristics and quality of care for ischemic stroke：analysis of the China National Stroke Registry and the American Heart Association get with the guidelines-stroke program[J/OL]. J Am Heart Assoc，2018，7（20）：e010623. https://doi.org/10.1161/JAHA.118.010623.
[33] 张通，李丽林，毕胜，等. 急性脑血管病三级康复治疗的前瞻性多中心随机对照研究[J]. 中华医学杂志，2004，84（23）：1948-1954.
Zhang Tong，Li Lilin，Bi Sheng，et al. A prospective multicenter randomized controlled study on three-grade rehabilitation treatment for patients with acute cerebrovascular diseases[J]. Natl Med J China，2004，84（23）：1948-1954.
[34] 陈卓，高颖，张通. 远程康复在脑卒中患者中的应用进展[J]. 中国康复医学杂志，2023，38（1）：108-113.
Chen Zhuo，Gao Ying，Zhang Tong. Research progress of telerehabilitation in patients with stroke[J]. Chin J Rehabil Med，2023，38（1）：108-113.
[35] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国缺血性卒中和短暂性脑缺血发作二级预防指南2022[J]. 中华神经科杂志，2022，55（10）：1073-1110.
Chinese Society of Neurology，Cerebrovascular Disease Study Group of Chinese Society of Neurology. Chinese guideline for the secondary prevention of ischemic stroke and transient ischemic attack 2022[J]. Chin J Neurol，2022，55（10）：1073-1110.
[36] 国家卫生健康委员会办公厅. 脑血管病防治指南（2024年版）[EB/OL].（2024-12-10）[2026-05-28]. https://www.nhc.gov.cn/ylyjs/zcwj/202412/ba037e931fff4870930f65ff667ea9ed/files/1736390751587_80714.pdf.
[37] Jiang Yue，Yang Xiaoming，Li Zixiao，et al. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China[J]. Neurol Res，2017，39（6）：492-497.
[38] 陈艳雪，姜悦，李子孝，等. 中国急性缺血性卒中及短暂性脑缺血发作二级预防药物依从性的现状[J]. 中国卒中杂志，2018，13（7）：686-691.
Chen Yanxue，Jiang Yue，Li Zixiao，et al. Status of medication adherence for secondary prevention in patients with acute ischemic stroke and transient ischemic attack in China[J]. Chin J Stroke，2018，13（7）：686-691.
[39] 贾杰. 脑卒中全周期康复的思考与策略[J]. 中国全科医学，2025，28（2）：129-134.
Jia Jie. Reflection and strategy of whole-cycle rehabilitation of stroke[J]. Chin Gen Pract，2025，28（2）：129-134.
[40] 中共中央，国务院.“健康中国2030”规划纲要[EB/OL].（2016-10-25）[2026-05-28]. https://www.gov.cn/zhengce/202203/content_3635233.htm.
[41] 国家卫生健康委. 关于印发加强脑卒中防治工作减少百万新发残疾工程综合方案的通知[EB/OL].（2021-06-18）[2026-05-28]. https://www.nhc.gov.cn/yzygj/c100068/202106/543eb8e17cdd44fe8165d8a627be85e0.shtml.
[42] 国家卫生健康委. 关于印发健康中国行动—心脑血管疾病防治行动实施方案（2023—2030年）的通知[EB/OL].（2023-10-30）[2026-05-28]. https://www.nhc.gov.cn/wjw/c100375/202311/547c69afe3364649a730dcc9e69d231c.shtml.
[43] 国家基层糖尿病防治管理办公室，中华医学会糖尿病学分会. 国家基层糖尿病防治管理指南（2022）[J]. 中华内科杂志，2022，61（3）：249-262.
National Office for Primary Diabetes Care，Diabetes Society of Chinese Medical Association. Guideline for primary care of diabetes in China（2022）[J]. Chin J Intern Med，2022，61（3）：249-262.
[44] 中国血脂管理指南修订联合专家委员会. 中国血脂管理指南（基层版 2024年）[J]. 中国循环杂志，2024，39（4）：313-321.
Joint Expert Committee on Revision of Guideline for Lipid Management in China. Guideline for lipid management in China（Primary Care Edition 2024）[J]. Chin Circ J，2024，39（4）：313-321.
[45] 国家卫生健康委基层卫生健康司. 国家卫生健康委财政部人力资源社会保障部国家医保局国家中医药局国家疾控局关于推进家庭医生签约服务高质量发展的指导意见[EB/OL].（2022-03-15）[2026-05-28]. https://www.nhc.gov.cn/jws/c100073/202203/ae7fd08b2d4545a9a2032a4cb8de5951.shtml.
[46] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发2021年国家医疗质量安全改进目标的通知[EB/OL].（2021-02-09）[2026-05-28]. https://www.nhc.gov.cn/yzygj/c100068/202102/116305f4cb174ef59b02be71ac826b6b.shtml.
[47] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发2022年国家医疗质量安全改进目标的通知[EB/OL].（2022-03-02）[2026-05-28]. https://www.nhc.gov.cn/yzygj/c100068/202203/d5e4af0c96814da3974d25df0bfad607.shtml.
[48] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发2023年国家医疗质量安全改进目标的通知[EB/OL].（2023-02-24）[2026-05-28]. https://www.nhc.gov.cn/wjw/c100378/202302/da18a1007f1c48dc9da63db77aef8ab4.shtml.
[49] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发2024年国家医疗质量安全改进目标的通知[EB/OL].（2024-02-01）[2026-05-28]. https://www.nhc.gov.cn/wjw/c100378/202402/0d948d3884f44e3986b36c4f1448d4f0.shtml.
[50] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发2025年国家医疗质量安全改进目标的通知[EB/OL].（2025-03-21）[2026-05-28]. https://www.nhc.gov.cn/yzygj/c100068/202503/ad63fb8ce9e24013a68db52049ecc524.shtml.
[51] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发2026年国家医疗质量安全改进目标的通知[EB/OL].（2026-02-14）[2026-05-28]. https://www.nhc.gov.cn/yzygj/c100068/202603/9f642951b99c447f8cff9da8abb74dc3.shtml
[52] 中国卒中学会，中国医师协会神经内科医师分会. 中国急性缺血性卒中远程诊疗专家共识[J]. 中国卒中杂志，2022，17（6）：589-602.
Chinese Stroke Association，Neurologist Branch of Chinese Medical Doctor Association. Expert consensus on telestroke for acute ischemic stroke in China[J]. Chin J Stroke，2022，17（6）：589-602.
[53] 国家卫生健康委. 关于加快推进康复医疗工作发展的意见[EB/OL].（2021-06-08）[2026-05-28]. https://www.nhc.gov.cn/yzygj/c100068/202106/54832e92612a4a2c947b8a36d7c305ca.shtml.
[54] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于开展康复医疗服务试点工作的通知[EB/OL].（2021-10-27）[2026-05-28]. https://www.nhc.gov.cn/yzygj/c100068/202110/45f547d11f58401793da6e03d51a6a5f.shtml
[55] 国务院. 国务院关于实施健康中国行动的意见[EB/OL].（2019-07-15）[2026-05-28]. https://www.gov.cn/zhengce/content/2019-07/15/content_5409492.htm.

Taking the Global Stroke Resolution as an Opportunity to Promote High-Quality Development of Cerebrovascular Disease Prevention and Treatment in China

以全球卒中决议为契机，推动中国脑血管病防治高质量发展

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	WANG Haili, CAO Liming, GUO Zhenni, YANG Yi, REN Lijie. From Vascular Imaging to Cerebral Function Assessment: Research Advances in Cervicocephalic Vascular Ultrasound in the Full-Course Management of Stroke [J]. Chinese Journal of Stroke, 2026, 21(8): 921-927.
[2]	WANG Jing, QU Yang, GUO Zhenni, YANG Yi. Association between Cerebral Autoregulation and Outcomes in Patients with Different Subtypes of Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2026, 21(8): 929-936.
[3]	WU Jiarui, ZHAO Yingying, WANG Jing, SHI Rui, CHI Feng, CAO Liming, REN Lijie. Association between Different Shunt Types on Contrast-Enhanced Transesophageal Echocardiography and Ischemic Stroke [J]. Chinese Journal of Stroke, 2026, 21(8): 943-948.
[4]	WANG Xingyang, LIU Quanying, CHEN Huisheng. Effect of Prior Stroke/TIA History on the Efficacy of Remote Ischemic Preconditioning for Cerebral Circulation Time in Severe Internal Carotid Artery Stenosis: A Post Hoc Analysis of RIC-CCT Trial [J]. Chinese Journal of Stroke, 2026, 21(8): 954-959.
[5]	LIU Yang, ZHENG Anji, YUAN Zinan, LI Siqi, ZHANG Yumei. Effect of Repetitive Transcranial Magnetic Stimulation Targeting the Cerebellum in the Rehabilitation of Patients with Post-Stroke Aphasia [J]. Chinese Journal of Stroke, 2026, 21(8): 960-969.
[6]	CHENG Li, YE Jianing, XU Yuluan, FAN Jinghua, DONG Fang, HAN Xinggui, WU Zongyi, YE Shujun, SI Fuzhong. Analysis of Incidence Trends and Distribution Characteristics of Acute Ischemic Stroke in Tengzhou City, Shandong Province from 2013 to 2021 [J]. Chinese Journal of Stroke, 2026, 21(8): 986-994.
[7]	Chinese Stroke Association, Writing Group of the Expert Consensus on Clinical Application of PCSK9 Inhibitors in Secondary Prevention of Ischemic Stroke (2026 Edition). Expert Consensus on Clinical Application of PCSK 9 Inhibitors in Secondary Prevention of Ischemic Stroke (2026 Edition) [J]. Chinese Journal of Stroke, 2026, 21(8): 995-1007.
[8]	WU Meiyan, ZHANG Fan. Mechanisms and Clinical Significance of Protein Glycosylation Modification in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2026, 21(8): 1038-1043.
[9]	WANG Tingting, CHEN Huisheng. Advances and Prospects in Non-Pharmacological Treatment of Acute Ischemic Stroke: From Mechanisms and Strategies to Evidence [J]. Chinese Journal of Stroke, 2026, 21(7): 797-803.
[10]	LI Ying, CUI Yu, LONG Yuxia, GUO Xuanyu, CHEN Huisheng. Effect of Antidiabetic Drugs on the Outcomes of Remote Ischemic Conditioning in Patients with Diabetes Mellitus Complicated by Acute Ischemic Stroke: A Post-Hoc Analysis of the RICAMIS Trial [J]. Chinese Journal of Stroke, 2026, 21(7): 805-813.
[11]	WU Qiong, ZHANG Nannan, ZHANG Yina, CHEN Huisheng. Association between Responsible Artery Stenosis Rate and Efficacy of Head-Down Position Therapy in Moderate Acute Ischemic Stroke: A Subgroup Analysis of the HOPES 2 Trial [J]. Chinese Journal of Stroke, 2026, 21(7): 814-822.
[12]	GAO Dan, CHEN Huisheng. Effect of Stroke Severity on the Efffcacy of Head-Down Position Therapy in Acute Ischemic Stroke: A Post-Hoc Analysis of the HOPES 2 Trial [J]. Chinese Journal of Stroke, 2026, 21(7): 823-828.
[13]	NIU Jingyuan, WU Qiong, CUI Yu, KONG Ying, WANG Tingting, LUO Xin, LI Xiandong, ZHAO Qiankun, WANG Haiyan, CHEN Huisheng. Electroacupuncture as an Adjuvant Therapy for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials [J]. Chinese Journal of Stroke, 2026, 21(7): 829-838.
[14]	JIA Shanshan, CHEN Huisheng. Vagus Nerve Stimulation for Stroke: Mechanisms and Advances [J]. Chinese Journal of Stroke, 2026, 21(7): 839-847.
[15]	XUE Xing, ZHOU Xiaoqi, CHENG Jie, LIANG Yanchao, TANG Qiqun, SONG Lihua, LIU Pingping, FENG Yina. Remote Ischemic Conditioning Training Improves Frailty, Anxiety, and Depression in Elderly Patients with Mild Ischemic Stroke [J]. Chinese Journal of Stroke, 2026, 21(7): 848-853.